VECURONIUM BROMIDE
Details
- Status
- Prescription
- First Approved
- 1995-08-31
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
VECURONIUM BROMIDE Approval History
What VECURONIUM BROMIDE Treats
12 FDA approvalsOriginally approved for its first indication in 1995 . Covers 12 distinct patient populations.
- Other (12)
Other
(12 approvals)- • Approved indication (Aug 1995)
- • Approved indication (Aug 1999)Letter
- • Approved indication (Aug 1999)Letter
- • Approved indication (Oct 1999)Letter
- • Approved indication (Jun 2000)Letter
- • Approved indication (Sep 2001)Letter
- • Approved indication (Dec 2008)
- • Approved indication (Jun 2009)
- • Approved indication (May 2010)
- • Approved indication (May 2016)
- • Approved indication (Dec 2018)
- • Approved indication (Jul 2019)
VECURONIUM BROMIDE Boxed Warning
THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATELY TRAINED INDIVIDUALS FAMILIAR WITH ITS ACTIONS, CHARACTERISTICS, AND HAZARDS....
THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATELY TRAINED INDIVIDUALS FAMILIAR WITH ITS ACTIONS, CHARACTERISTICS, AND HAZARDS.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
VECURONIUM BROMIDE FDA Label Details
ProIndications & Usage
FDA Label (PDF)Vecuronium bromide for injection is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATELY TRAINED INDIVIDUALS FAMILIAR WITH ITS ACTIONS, CHARACTERISTICS, AND HAZARDS....
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.